Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction Agnieszka Toma-JonikNatalia VydraWiesława Widłak Review Open access 10 June 2019 Pages: 579 - 589
Tumor-associated macrophages: role in cancer development and therapeutic implications Arash SalmaninejadSaeed Farajzadeh ValilouAmirhossein Sahebkar Review 29 May 2019 Pages: 591 - 608
Recent advances in the clinical development of immune checkpoint blockade therapy Atefeh GhahremanlooArash SoltaniSeyed Isaac Hashemy Review 14 June 2019 Pages: 609 - 626
Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy Ginés Luengo-GilElena García-MartínezFrancisco Ayala de la Peña Original Paper 21 May 2019 Pages: 627 - 644
Molecular profiling of anastatic cancer cells: potential role of the nuclear export pathway Mahendra SeerviS. SumiT. R. SanthoshKumar Original Paper 30 May 2019 Pages: 645 - 661
The role of TNF-α in chordoma progression and inflammatory pathways Sukru GulluogluEmre Can TuysuzOmer Faruk Bayrak Original Paper 07 June 2019 Pages: 663 - 677
Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells Lihua ChenXi ChengZiliang Wang Original paper Open access 20 July 2019 Pages: 679 - 690
Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration Yvette J. E. SlootKatrin RaboldRomana T. Netea-Maier Original paper Open access 14 June 2019 Pages: 691 - 703
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells Florian P. ReiterGerald DenkEnrico N. De Toni Original Paper 27 June 2019 Pages: 705 - 715
Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial Stéphanie ZunderPriscilla van der WilkWilma Mesker Report Open access 17 May 2019 Pages: 717 - 725